BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Xu J. DNA methyltransferases and their roles in tumorigenesis. Biomark Res 2017;5:1. [PMID: 28127428 DOI: 10.1186/s40364-017-0081-z] [Cited by in Crossref: 115] [Cited by in F6Publishing: 109] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Bilyard MK, Becker S, Balasubramanian S. Natural, modified DNA bases. Current Opinion in Chemical Biology 2020;57:1-7. [DOI: 10.1016/j.cbpa.2020.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Leung JY, Chia K, Ong DST, Taneja R. Interweaving Tumor Heterogeneity into the Cancer Epigenetic/Metabolic Axis. Antioxid Redox Signal 2020;33:946-65. [PMID: 31841357 DOI: 10.1089/ars.2019.7942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Iguchi E, Takai A, Takeda H, Kumagai K, Arasawa S, Eso Y, Shimizu T, Ueda Y, Marusawa H, Seno H. DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis. Sci Rep 2020;10:21268. [PMID: 33277576 DOI: 10.1038/s41598-020-78151-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Zhao Y, Oreskovic E, Zhang Q, Lu Q, Gilman A, Lin YS, He J, Zheng Z, Lu JY, Lee J, Ke Z, Ablaeva J, Sweet MJ, Horvath S, Zhang Z, Nevo E, Seluanov A, Gorbunova V. Transposon-triggered innate immune response confers cancer resistance to the blind mole rat. Nat Immunol 2021;22:1219-30. [PMID: 34556881 DOI: 10.1038/s41590-021-01027-8] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sher G, Salman NA, Khan AQ, Prabhu KS, Raza A, Kulinski M, Dermime S, Haris M, Junejo K, Uddin S. Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications. Semin Cancer Biol 2020:S1044-579X(20)30181-4. [PMID: 32858230 DOI: 10.1016/j.semcancer.2020.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Charostad J, Astani A, Goudarzi H, Faghihloo E. DNA methyltransferases in virus-associated cancers. Rev Med Virol 2019;29:e2022. [PMID: 30511446 DOI: 10.1002/rmv.2022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lobo J, Guimarães R, Miranda-Gonçalves V, Monteiro-Reis S, Cantante M, Antunes L, Braga I, Maurício J, Looijenga LH, Jerónimo C, Henrique R. Differential expression of DNA methyltransferases and demethylases among the various testicular germ cell tumor subtypes. Epigenomics 2020;12:1579-92. [PMID: 32957806 DOI: 10.2217/epi-2020-0066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Lu W, Zhang R, Jiang H, Zhang H, Luo C. Computer-Aided Drug Design in Epigenetics. Front Chem 2018;6:57. [PMID: 29594101 DOI: 10.3389/fchem.2018.00057] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
9 Chatterjee B, Ghosh K, Kanade SR. Curcumin‐mediated demethylation of the proximal promoter CpG island enhances the KLF4 recruitment that leads to increased expression of p21Cip1 in vitro. J Cell Biochem 2019;120:809-20. [DOI: 10.1002/jcb.27442] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
10 Román GC, Mancera-Páez O, Bernal C. Epigenetic Factors in Late-Onset Alzheimer's Disease: MTHFR and CTH Gene Polymorphisms, Metabolic Transsulfuration and Methylation Pathways, and B Vitamins. Int J Mol Sci 2019;20:E319. [PMID: 30646578 DOI: 10.3390/ijms20020319] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
11 Basura GJ, Smith JD, Ellsperman S, Bhangale A, Brenner JC. Targeted molecular characterization of external auditory canal squamous cell carcinomas. Laryngoscope Investig Otolaryngol 2021;6:1151-7. [PMID: 34667860 DOI: 10.1002/lio2.654] [Reference Citation Analysis]
12 Yu J, Xie T, Wang Z, Wang X, Zeng S, Kang Y, Hou T. DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs. Drug Discov Today 2019;24:2323-31. [PMID: 31494187 DOI: 10.1016/j.drudis.2019.08.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
13 Shanak S, Helms V. DNA methylation and the core pluripotency network. Dev Biol 2020;464:145-60. [PMID: 32562758 DOI: 10.1016/j.ydbio.2020.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Tanna B, Yadav S, Mishra A. Anti-proliferative and ROS-inhibitory activities reveal the anticancer potential of Caulerpa species. Mol Biol Rep 2020;47:7403-11. [PMID: 32990904 DOI: 10.1007/s11033-020-05795-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Lauschke VM, Zhou Y, Ingelman-Sundberg M. Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity. Pharmacol Ther 2019;197:122-52. [PMID: 30677473 DOI: 10.1016/j.pharmthera.2019.01.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
16 Nagy A, Bhaduri A, Shahmarvand N, Shahryari J, Zehnder JL, Warnke RA, Mughal T, Ali S, Ohgami RS. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Blood Adv. 2018;2:481-491. [PMID: 29496669 DOI: 10.1182/bloodadvances.2017009654] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
17 Sangkert S, Kamolmatyakul S, Meesane J. The bone-mimicking effect of calcium phosphate on composite chitosan scaffolds in maxillofacial bone tissue engineering. J Appl Biomater Funct Mater 2020;18:2280800019893204. [PMID: 32297820 DOI: 10.1177/2280800019893204] [Reference Citation Analysis]
18 Hu C, Liu X, Zeng Y, Liu J, Wu F. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clin Epigenetics 2021;13:166. [PMID: 34452630 DOI: 10.1186/s13148-021-01154-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Casalino L, Verde P. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis. Genes (Basel) 2020;11:E922. [PMID: 32806509 DOI: 10.3390/genes11080922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
20 Fallico M, Raciti G, Longo A, Reibaldi M, Bonfiglio V, Russo A, Caltabiano R, Gattuso G, Falzone L, Avitabile T. Current molecular and clinical insights into uveal melanoma (Review). Int J Oncol 2021;58:10. [PMID: 33649778 DOI: 10.3892/ijo.2021.5190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
21 Miranda Furtado CL, Dos Santos Luciano MC, Silva Santos RD, Furtado GP, Moraes MO, Pessoa C. Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics 2019;14:1164-76. [PMID: 31282279 DOI: 10.1080/15592294.2019.1640546] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
22 Gjerstorff MF. Novel Insights Into Epigenetic Reprogramming and Destabilization of Pericentromeric Heterochromatin in Cancer. Front Oncol 2020;10:594163. [PMID: 33251148 DOI: 10.3389/fonc.2020.594163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Lamim Lovatel V, de Souza Fernandez C, Ferreira Rodrigues E, de Cassia Tavares R, Sobral da Costa E, Abdelhay E, Coelho Soares Lima S, de Souza Fernandez T. Expression Profiles of DNA Methylation and Demethylation Machinery Components in Pediatric Myelodysplastic Syndrome: Clinical Implications. Cancer Manag Res 2020;12:543-56. [PMID: 32158259 DOI: 10.2147/CMAR.S219026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Schiffer M, Zhao J, Johnson A, Lee J, Bewersdorf JP, Zeidan AM. The development and clinical use of oral hypomethylating agents in acute myeloid leukemia and myelodysplastic syndromes: dawn of the total oral therapy era. Expert Rev Anticancer Ther 2021;21:989-1002. [PMID: 33853476 DOI: 10.1080/14737140.2021.1918002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Balaji E V, Kumar N, Satarker S, Nampoothiri M. Zinc as a plausible epigenetic modulator of glioblastoma multiforme. Eur J Pharmacol 2020;887:173549. [PMID: 32926916 DOI: 10.1016/j.ejphar.2020.173549] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Larionova I, Rakina M, Ivanyuk E, Trushchuk Y, Chernyshova A, Denisov E. Radiotherapy resistance: identifying universal biomarkers for various human cancers. J Cancer Res Clin Oncol 2022. [PMID: 35113235 DOI: 10.1007/s00432-022-03923-4] [Reference Citation Analysis]
27 Grady WM. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer. Adv Cancer Res 2021;151:425-68. [PMID: 34148620 DOI: 10.1016/bs.acr.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ko EK, Capell BC. Methyltransferases in the Pathogenesis of Keratinocyte Cancers. Cancers (Basel) 2021;13:3402. [PMID: 34298617 DOI: 10.3390/cancers13143402] [Reference Citation Analysis]
29 Canale M, Casadei-Gardini A, Ulivi P, Arechederra M, Berasain C, Lollini PL, Fernández-Barrena MG, Avila MA. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. Int J Mol Sci 2020;21:E5500. [PMID: 32752096 DOI: 10.3390/ijms21155500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Vaghari-Tabari M, Targhazeh N, Moein S, Qujeq D, Alemi F, Majidina M, Younesi S, Asemi Z, Yousefi B. From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs? Cancer Cell Int 2022;22:146. [PMID: 35410210 DOI: 10.1186/s12935-022-02557-3] [Reference Citation Analysis]
31 Zhang J, Liu X, Zhang S, Cai Y, Ma K, Hua K, Cui Y. A site-specific DNA methylation biosensor for both visual and magnetic determination based on lateral flow assay. Analyst 2021;146:2248-54. [PMID: 33599220 DOI: 10.1039/d0an02277b] [Reference Citation Analysis]
32 Huang T, Zhou X, Mao X, Yu C, Zhang Z, Yang J, Zhang Y, Su T, Chen C, Cao Y, Wei H, Wu Z. Lactate-fueled oxidative metabolism drives DNA methyltransferase 1-mediated transcriptional co-activator with PDZ binding domain protein activation. Cancer Sci 2020;111:186-99. [PMID: 31746077 DOI: 10.1111/cas.14246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Poole CJ, Lodh A, Choi JH, van Riggelen J. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL. Epigenetics Chromatin 2019;12:41. [PMID: 31266538 DOI: 10.1186/s13072-019-0278-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
34 Yousefi B, Mohammadlou M, Abdollahi M, Salek Farrokhi A, Karbalaei M, Keikha M, Kokhaei P, Valizadeh S, Rezaiemanesh A, Arabkari V, Eslami M. Epigenetic changes in gastric cancer induction by Helicobacter pylori. J Cell Physiol 2019;234:21770-84. [DOI: 10.1002/jcp.28925] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
35 Zukowski A, Rao S, Ramachandran S. Phenotypes from cell-free DNA. Open Biol 2020;10:200119. [PMID: 32873154 DOI: 10.1098/rsob.200119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Romero-Medina MC, Venuti A, Melita G, Robitaille A, Ceraolo MG, Pacini L, Sirand C, Viarisio D, Taverniti V, Gupta P, Scalise M, Indiveri C, Accardi R, Tommasino M. Human papillomavirus type 38 alters wild-type p53 activity to promote cell proliferation via the downregulation of integrin alpha 1 expression. PLoS Pathog 2020;16:e1008792. [PMID: 32813746 DOI: 10.1371/journal.ppat.1008792] [Reference Citation Analysis]
37 Honeywell RJ, Sarkisjan D, Kristensen MH, de Klerk DJ, Peters GJ. DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors. Nucleosides Nucleotides Nucleic Acids 2018;37:696-708. [PMID: 30663502 DOI: 10.1080/15257770.2018.1498516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
38 Oliver J, Garcia-Aranda M, Chaves P, Alba E, Cobo-Dols M, Onieva JL, Barragan I. Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction. Semin Cancer Biol 2021:S1044-579X(21)00062-6. [PMID: 33757849 DOI: 10.1016/j.semcancer.2021.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Furst AL, Muren NB, Hill MG. Toward multimarker and functional assays from crude cell lysates: controlling spacing and signal amplification in DNA-CT–based bioelectrochemical devices. Current Opinion in Electrochemistry 2019;14:104-12. [DOI: 10.1016/j.coelec.2018.12.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
40 Quazi S. Elucidation of CRISPR-Cas9 application in novel cellular immunotherapy. Mol Biol Rep. [DOI: 10.1007/s11033-022-07147-0] [Reference Citation Analysis]
41 Mittal R, Bencie N, Liu G, Eshraghi N, Nisenbaum E, Blanton SH, Yan D, Mittal J, Dinh CT, Young JI, Gong F, Liu XZ. Recent advancements in understanding the role of epigenetics in the auditory system. Gene 2020;761:144996. [PMID: 32738421 DOI: 10.1016/j.gene.2020.144996] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Riasat K, Bardell D, Goljanek-Whysall K, Clegg PD, Peffers MJ. Epigenetic mechanisms in Tendon Ageing. Br Med Bull 2020;135:90-107. [PMID: 32827252 DOI: 10.1093/bmb/ldaa023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Clark DJ, Schnaubelt M, Hoti N, Hu Y, Zhou Y, Gooya M, Zhang H. Impact of Increased FUT8 Expression on the Extracellular Vesicle Proteome in Prostate Cancer Cells. J Proteome Res 2020;19:2195-205. [PMID: 32378902 DOI: 10.1021/acs.jproteome.9b00578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
44 He J, He H, Qi Y, Yang J, Zhi L, Jia Y. Application of epigenetics in dermatological research and skin management. J Cosmet Dermatol 2021. [PMID: 34357681 DOI: 10.1111/jocd.14355] [Reference Citation Analysis]
45 Xiao W, Zhou Q, Wen X, Wang R, Liu R, Wang T, Shi J, Hu Y, Hou J. Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy. Front Pharmacol 2021;12:702360. [PMID: 34603017 DOI: 10.3389/fphar.2021.702360] [Reference Citation Analysis]
46 Candido S, Parasiliti Palumbo GA, Pennisi M, Russo G, Sgroi G, Di Salvatore V, Libra M, Pappalardo F. EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation. BMC Bioinformatics 2019;19:385. [PMID: 30717649 DOI: 10.1186/s12859-018-2397-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Costantino S, Paneni F. The Epigenome in Atherosclerosis. Handb Exp Pharmacol 2021. [PMID: 33474673 DOI: 10.1007/164_2020_422] [Reference Citation Analysis]
48 Flausino CS, Daniel FI, Modolo F. DNA methylation in oral squamous cell carcinoma: from its role in carcinogenesis to potential inhibitor drugs. Crit Rev Oncol Hematol 2021;164:103399. [PMID: 34147646 DOI: 10.1016/j.critrevonc.2021.103399] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Shukla V, Samaniego-Castruita D, Dong Z, González-Avalos E, Yan Q, Sarma K, Rao A. TET deficiency perturbs mature B cell homeostasis and promotes oncogenesis associated with accumulation of G-quadruplex and R-loop structures. Nat Immunol 2022;23:99-108. [PMID: 34937926 DOI: 10.1038/s41590-021-01087-w] [Reference Citation Analysis]
50 Berglund A, Putney RM, Hamaidi I, Kim S. Epigenetic dysregulation of immune-related pathways in cancer: bioinformatics tools and visualization. Exp Mol Med 2021;53:761-71. [PMID: 33963293 DOI: 10.1038/s12276-021-00612-z] [Reference Citation Analysis]
51 Takahashi H, Okayama N, Yamaguchi N, Nomura M, Miyahara Y, Mahbub MH, Hase R, Morishima Y, Suehiro Y, Yamasaki T, Tamada K, Takahashi S, Tojo A, Tanabe T. Analysis of Relationships between Immune Checkpoint and Methylase Gene Polymorphisms and Outcomes after Unrelated Bone Marrow Transplantation. Cancers (Basel) 2021;13:2752. [PMID: 34206082 DOI: 10.3390/cancers13112752] [Reference Citation Analysis]
52 de Melo FHM, Oliveira JS, Sartorelli VOB, Montor WR. Cancer Chemoprevention: Classic and Epigenetic Mechanisms Inhibiting Tumorigenesis. What Have We Learned So Far? Front Oncol 2018;8:644. [PMID: 30627525 DOI: 10.3389/fonc.2018.00644] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
53 Budi HS, Ahmad FN, Achmad H, Ansari MJ, Mikhailova MV, Suksatan W, Chupradit S, Shomali N, Marofi F. Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-02719-0] [Reference Citation Analysis]
54 Tang X, Tu G, Yang G, Wang X, Kang L, Yang L, Zeng H, Wan X, Qiao Y, Cui X, Liu M, Hou Y. Autocrine TGF-β1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation. Cancer Lett 2019;452:79-89. [PMID: 30851420 DOI: 10.1016/j.canlet.2019.02.044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
55 Liu X, Gong Y. Isocitrate dehydrogenase inhibitors in acute myeloid leukemia. Biomark Res 2019;7:22. [PMID: 31660152 DOI: 10.1186/s40364-019-0173-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
56 Storti CB, de Oliveira RA, de Carvalho M, Hasimoto EN, Cataneo DC, Cataneo AJM, De Faveri J, Vasconcelos EJR, Dos Reis PP, Cano MIN. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC). Exp Mol Pathol 2020;112:104354. [PMID: 31837325 DOI: 10.1016/j.yexmp.2019.104354] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
57 Magalhães M, Jorge J, Gonçalves AC, Sarmento-Ribeiro AB, Carvalho R, Figueiras A, Santos AC, Veiga F. miR-29b and retinoic acid co-delivery: a promising tool to induce a synergistic antitumoral effect in non-small cell lung cancer cells. Drug Deliv Transl Res 2020;10:1367-80. [PMID: 32358723 DOI: 10.1007/s13346-020-00768-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Yu YC, Hui TZ, Kao TH, Liao HF, Yang CY, Hou CC, Hsieh HT, Chang JY, Tsai YT, Pinskaya M, Yang KC, Chen YR, Morillon A, Tsai MH, Lin SP. Transient DNMT3L Expression Reinforces Chromatin Surveillance to Halt Senescence Progression in Mouse Embryonic Fibroblast. Front Cell Dev Biol 2020;8:103. [PMID: 32195249 DOI: 10.3389/fcell.2020.00103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Harandi-Zadeh S, Boycott C, Beetch M, Yang T, Martin BJE, Ren K, Kwasniak A, Dupuis JH, Lubecka K, Yada RY, Howe LJ, Stefanska B. Pterostilbene Changes Epigenetic Marks at Enhancer Regions of Oncogenes in Breast Cancer Cells. Antioxidants (Basel) 2021;10:1232. [PMID: 34439480 DOI: 10.3390/antiox10081232] [Reference Citation Analysis]
60 Magno Guimarães D, deLucas da Silva Almeida F, Moraes Castilho R, Eduardo Nor J, Daumas Nunes F. DNA methyltransferase expression is associated with cell proliferation in salivary mucoepidermoid carcinoma. J Oral Pathol Med 2020;49:1053-60. [PMID: 32740989 DOI: 10.1111/jop.13092] [Reference Citation Analysis]
61 Ghosh K, Chatterjee B, Kanade SR. Lead induces the up-regulation of the protein arginine methyltransferase 5 possibly by its promoter demethylation. Biochem J 2018;475:2653-66. [PMID: 30054435 DOI: 10.1042/BCJ20180009] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
62 Mancarella D, Plass C. Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation. Genome Med. 2021;13:23. [PMID: 33568205 DOI: 10.1186/s13073-021-00837-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
63 Mensah IK, Norvil AB, AlAbdi L, McGovern S, Petell CJ, He M, Gowher H. Misregulation of the expression and activity of DNA methyltransferases in cancer. NAR Cancer 2021;3:zcab045. [PMID: 34870206 DOI: 10.1093/narcan/zcab045] [Reference Citation Analysis]
64 Degryse S, de Bock CE, Demeyer S, Govaerts I, Bornschein S, Verbeke D, Jacobs K, Binos S, Skerrett-Byrne DA, Murray HC, Verrills NM, Van Vlierberghe P, Cools J, Dun MD. Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia. Leukemia 2018;32:788-800. [PMID: 28852199 DOI: 10.1038/leu.2017.276] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
65 Chatterjee B, Ghosh K, Swain A, Nalla KK, Ravula H, Pan A, Kanade SR. The phytochemical brazilin suppress DNMT1 expression by recruiting p53 to its promoter resulting in the epigenetic restoration of p21 in MCF7cells. Phytomedicine 2021;95:153885. [PMID: 34920321 DOI: 10.1016/j.phymed.2021.153885] [Reference Citation Analysis]
66 Li Q, Cai M, Wang J, Gao Q, Guo X, Jia X, Xu S, Zhu H. Decreased ovarian function and autophagy gene methylation in aging rats. J Ovarian Res 2020;13:12. [PMID: 32014030 DOI: 10.1186/s13048-020-0615-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
67 Kundu S, Ray MD, Sharma A. Interplay between genome organization and epigenomic alterations of pericentromeric DNA in cancer. J Genet Genomics 2021;48:184-97. [PMID: 33840602 DOI: 10.1016/j.jgg.2021.02.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Blum MGB, Valeri L, François O, Cadiou S, Siroux V, Lepeule J, Slama R. Challenges Raised by Mediation Analysis in a High-Dimension Setting. Environ Health Perspect 2020;128:55001. [PMID: 32379489 DOI: 10.1289/EHP6240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
69 Ozyerli-Goknar E, Bagci-Onder T. Epigenetic Deregulation of Apoptosis in Cancers. Cancers (Basel) 2021;13:3210. [PMID: 34199020 DOI: 10.3390/cancers13133210] [Reference Citation Analysis]
70 Zhu J, Wu Q, Wang J, Niu T. Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia. Expert Rev Hematol 2022. [PMID: 35437111 DOI: 10.1080/17474086.2022.2061456] [Reference Citation Analysis]
71 Gurbuz V, Sozen S, Bilen CY, Konac E. miR-148a, miR-152 and miR-200b promote prostate cancer metastasis by targeting DNMT1 and PTEN expression. Oncol Lett 2021;22:805. [PMID: 34630712 DOI: 10.3892/ol.2021.13066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Bruine de Bruin L, Clausen MJAM, Slagter-Menkema L, de Bock GH, Langendijk JA, van der Vegt B, van der Laan BFAM, Schuuring E. High DNMT1 Is Associated With Worse Local Control in Early-Stage Laryngeal Squamous Cell Carcinoma. Laryngoscope 2021. [PMID: 34427325 DOI: 10.1002/lary.29833] [Reference Citation Analysis]
73 Bernardi A, Sarkis M, Triantafyllou N, Lakelin M, Shah N, Papathanasiou MM. Assessment of intermediate storage and distribution nodes in personalised medicine. Computers & Chemical Engineering 2022;157:107582. [DOI: 10.1016/j.compchemeng.2021.107582] [Reference Citation Analysis]
74 Su CW, Chang YC, Chien MH, Hsieh YH, Chen MK, Lin CW, Yang SF. Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis. Cell Death Dis 2019;10:793. [PMID: 31624299 DOI: 10.1038/s41419-019-2016-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
75 Phanus-Umporn C, Prachayasittikul V, Nantasenamat C, Prachayasittikul S, Prachayasittikul V. QSAR-driven rational design of novel DNA methyltransferase 1 inhibitors. EXCLI J 2020;19:458-75. [PMID: 32398970 DOI: 10.17179/excli2020-1096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Vashi R, Patel BM, Goyal RK. Keeping abreast about ashwagandha in breast cancer. J Ethnopharmacol 2021;269:113759. [PMID: 33359916 DOI: 10.1016/j.jep.2020.113759] [Reference Citation Analysis]
77 Gilad Y, Eliaz Y, Yu Y, Dean AM, Han SJ, Qin L, O'Malley BW, Lonard DM. A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells. Commun Biol 2021;4:399. [PMID: 33767353 DOI: 10.1038/s42003-021-01929-1] [Reference Citation Analysis]
78 Karimzadeh MR, Pourdavoud P, Ehtesham N, Qadbeigi M, Asl MM, Alani B, Mosallaei M, Pakzad B. Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy. Cancer Gene Ther 2021;28:157-74. [PMID: 32773776 DOI: 10.1038/s41417-020-00210-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
79 Vijayaraghavalu S, Labhasetwar V. Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells. Drug Deliv Transl Res 2018;8:1289-99. [PMID: 29947019 DOI: 10.1007/s13346-018-0556-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
80 Braný D, Dvorská D, Grendár M, Ňachajová M, Szépe P, Lasabová Z, Žúbor P, Višňovský J, Halášová E. Different methylation levels in the KLF4, ATF3 and DLEC1 genes in the myometrium and in corpus uteri mesenchymal tumours as assessed by MS-HRM. Pathol Res Pract 2019;215:152465. [PMID: 31176573 DOI: 10.1016/j.prp.2019.152465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Nieborak A, Schneider R. Metabolic intermediates - Cellular messengers talking to chromatin modifiers. Mol Metab 2018;14:39-52. [PMID: 29397344 DOI: 10.1016/j.molmet.2018.01.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
82 Gujar H, Weisenberger DJ, Liang G. The Roles of Human DNA Methyltransferases and Their Isoforms in Shaping the Epigenome. Genes (Basel) 2019;10:E172. [PMID: 30813436 DOI: 10.3390/genes10020172] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 22.0] [Reference Citation Analysis]
83 Su JF, Zhao F, Gao ZW, Hou YJ, Li YY, Duan LJ, Lun SM, Yang HJ, Li JK, Dai NT, Shen FF, Zhou FY. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B. Pathol Res Pract 2020;216:152848. [PMID: 32051106 DOI: 10.1016/j.prp.2020.152848] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
84 Ramassone A, Pagotto S, Veronese A, Visone R. Epigenetics and MicroRNAs in Cancer. Int J Mol Sci 2018;19:E459. [PMID: 29401683 DOI: 10.3390/ijms19020459] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 19.0] [Reference Citation Analysis]
85 Khrabrova DA, Loiko AG, Tolkacheva AA, Cherepanova NA, Zvereva MI, Kirsanova OV, Gromova ES. Functional Analysis of DNMT3A DNA Methyltransferase Mutations Reported in Patients with Acute Myeloid Leukemia. Biomolecules 2019;10:E8. [PMID: 31861499 DOI: 10.3390/biom10010008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
86 Chu D, Li J, Lin H, Zhang X, Pan H, Liu L, Yu T, Yan M, Yao M. Quantitative proteomic analysis of the miR-148a-associated mechanisms of metastasis in non-small cell lung cancer. Oncol Lett 2018;15:9941-52. [PMID: 29928367 DOI: 10.3892/ol.2018.8581] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
87 Su CW, Lin CW, Yang WE, Yang SF. TIMP-3 as a therapeutic target for cancer. Ther Adv Med Oncol 2019;11:1758835919864247. [PMID: 31360238 DOI: 10.1177/1758835919864247] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
88 Shi F, Zhou M, Shang L, Du Q, Li Y, Xie L, Liu X, Tang M, Luo X, Fan J, Zhou J, Gao Q, Qiu S, Wu W, Zhang X, Bode AM, Cao Y. EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter. Theranostics 2019;9:2424-38. [PMID: 31131045 DOI: 10.7150/thno.30941] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
89 Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer. Int J Mol Sci 2019;20:E5758. [PMID: 31744051 DOI: 10.3390/ijms20225758] [Cited by in Crossref: 89] [Cited by in F6Publishing: 114] [Article Influence: 29.7] [Reference Citation Analysis]
90 Li L, Li F, Xia Y, Yang X, Lv Q, Fang F, Wang Q, Bu W, Wang Y, Zhang K, Wu Y, Shen J, Jiang M. UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes. EBioMedicine 2020;57:102835. [PMID: 32574963 DOI: 10.1016/j.ebiom.2020.102835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
91 [DOI: 10.1101/2021.01.13.426413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Sharma A, Tobar-Tosse F, Chand Dakal T, Liu H, Biswas A, Menon A, Paruchuri A, Katsonis P, Lichtarge O, Gromiha MM, Ludwig M, Schmidt-Wolf IGH, Holz FG, Loeffler KU, Herwig-Carl MC. PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPARγ-DNMT1 Interactions in the Genome. Cancers (Basel) 2021;13:3993. [PMID: 34439147 DOI: 10.3390/cancers13163993] [Reference Citation Analysis]
93 Rafat A, Dizaji Asl K, Mazloumi Z, Movassaghpour AA, Talebi M, Shanehbandi D, Farahzadi R, Nejati B, Nozad Charoudeh H. Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways. Life Sci 2022;295:120402. [PMID: 35176279 DOI: 10.1016/j.lfs.2022.120402] [Reference Citation Analysis]
94 Coppedè F, Stoccoro A, Tannorella P, Migliore L. Plasma Homocysteine and Polymorphisms of Genes Involved in Folate Metabolism Correlate with DNMT1 Gene Methylation Levels. Metabolites 2019;9:E298. [PMID: 31817852 DOI: 10.3390/metabo9120298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
95 Mastropasqua F, Girolimetti G, Shoshan M. PGC1α: Friend or Foe in Cancer? Genes (Basel) 2018;9:E48. [PMID: 29361779 DOI: 10.3390/genes9010048] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
96 Paço A, Freitas R. HOX genes as transcriptional and epigenetic regulators during tumorigenesis and their value as therapeutic targets. Epigenomics 2019;11:1539-52. [PMID: 31556724 DOI: 10.2217/epi-2019-0090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
97 Alvizo-Rodriguez CR, Ayala-Madrigal ML, Hernandez-Sandoval JA, Ramirez-Plascencia HHF, Gonzalez-Villaseñor CO, Macias-Gomez NM, Peregrina-Sandoval J, Moreno-Ortiz JM, Valenzuela-Perez JA, Cruz-Ramos JA, Gutierrez-Angulo M. Methylation analysis of MIR200 family in Mexican patients with colorectal cancer. J Investig Med 2020;68:782-5. [PMID: 31874934 DOI: 10.1136/jim-2019-001184] [Reference Citation Analysis]
98 Sweeney KJ, Mottolese C, Belot A, Szathmari A, Frappaz D, Lesca G, Putoux A, Di Rocco F. The first case report of medulloblastoma associated with Tatton-Brown-Rahman syndrome. Am J Med Genet A 2019;179:1357-61. [PMID: 31066180 DOI: 10.1002/ajmg.a.61180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
99 Tomasello L, Vezzalini M, Boni C, Bonifacio M, Scaffidi L, Yassin M, Al-Dewik N, Takam Kamga P, Krampera M, Sorio C. Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia. Int J Mol Sci 2020;21:E2298. [PMID: 32225105 DOI: 10.3390/ijms21072298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
100 Cervena K, Siskova A, Buchler T, Vodicka P, Vymetalkova V. Methylation-Based Therapies for Colorectal Cancer. Cells 2020;9:E1540. [PMID: 32599894 DOI: 10.3390/cells9061540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
101 Lin CC, Chen YP, Yang WZ, Shen JCK, Yuan HS. Structural insights into CpG-specific DNA methylation by human DNA methyltransferase 3B. Nucleic Acids Res 2020;48:3949-61. [PMID: 32083663 DOI: 10.1093/nar/gkaa111] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
102 Zamzami MA, Nasrullah M, Choudhry H, Khan MI. A Study on the Effect of Vitamins A and C to Modulate the Expression of NKG2D Ligands in Hepatic and Colon Cancer Cells. Nutr Cancer 2020;:1-12. [PMID: 33349056 DOI: 10.1080/01635581.2020.1860240] [Reference Citation Analysis]
103 Yang T, Liu X, Kumar SK, Jin F, Dai Y. Decoding DNA methylation in epigenetics of multiple myeloma. Blood Rev 2021;:100872. [PMID: 34384602 DOI: 10.1016/j.blre.2021.100872] [Reference Citation Analysis]
104 Shivakumar M, Miller JE, Dasari VR, Zhang Y, Lee MTM, Carey DJ, Gogoi R, Kim D; DiscovEHR collaboration. Genetic Analysis of Functional Rare Germline Variants across Nine Cancer Types from an Electronic Health Record Linked Biobank. Cancer Epidemiol Biomarkers Prev 2021;30:1681-8. [PMID: 34244158 DOI: 10.1158/1055-9965.EPI-21-0082] [Reference Citation Analysis]
105 Hirata E, Ishibashi K, Kohsaka S, Shinjo K, Kojima S, Kondo Y, Mano H, Yano S, Kiyokawa E, Sahai E. The Brain Microenvironment Induces DNMT1 Suppression and Indolence of Metastatic Cancer Cells. iScience 2020;23:101480. [PMID: 32891059 DOI: 10.1016/j.isci.2020.101480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
106 Veena KV, Siddamalla S, Deenadayal M, Shivaji S, Bhanoori M. DNMT1 and DNMT3B gene variants and their association with endometriosis in South Indian women. Mol Biol Rep 2021. [PMID: 34697715 DOI: 10.1007/s11033-021-06877-x] [Reference Citation Analysis]
107 Zheng F, Wu J, Tang Q, Xiao Q, Wu W, Hann SS. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1. J Cell Mol Med 2018;22:600-12. [PMID: 28840963 DOI: 10.1111/jcmm.13347] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
108 Ghosh K, Chatterjee B, Behera P, Kanade SR. The carcinogen cadmium elevates CpG-demethylation and enrichment of NFYA and E2F1 in the promoter of oncogenic PRMT5 and EZH2 methyltransferases resulting in their elevated expression in vitro. Chemosphere 2020;242:125186. [PMID: 31675590 DOI: 10.1016/j.chemosphere.2019.125186] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
109 Kinoshita M, Li MA, Barber M, Mansfield W, Dietmann S, Smith A. Disabling de novo DNA methylation in embryonic stem cells allows an illegitimate fate trajectory. Proc Natl Acad Sci U S A 2021;118:e2109475118. [PMID: 34518230 DOI: 10.1073/pnas.2109475118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Mafra D, Esgalhado M, Borges NA, Cardozo LFMF, Stockler-pinto MB, Craven H, Buchanan SJ, Lindholm B, Stenvinkel P, Shiels PG. Methyl Donor Nutrients in Chronic Kidney Disease: Impact on the Epigenetic Landscape. The Journal of Nutrition 2019;149:372-80. [DOI: 10.1093/jn/nxy289] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
111 Hsu PJ, Shi H, He C. Epitranscriptomic influences on development and disease. Genome Biol 2017;18:197. [PMID: 29061143 DOI: 10.1186/s13059-017-1336-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 10.4] [Reference Citation Analysis]
112 Elmhiri G, Gloaguen C, Grison S, Kereselidze D, Elie C, Tack K, Benderitter M, Lestaevel P, Legendre A, Souidi M. DNA methylation and potential multigenerational epigenetic effects linked to uranium chronic low-dose exposure in gonads of males and females rats. Toxicol Lett 2018;282:64-70. [PMID: 29024790 DOI: 10.1016/j.toxlet.2017.10.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
113 Shim J, Ryu J, Jeong SY, Cho Y, Choi J, Hwang JR, Choi J, Sa JK, Lee J. Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer. Gynecologic Oncology 2022. [DOI: 10.1016/j.ygyno.2022.03.005] [Reference Citation Analysis]
114 Ma S, Zhang WL, Leckey BD Jr, Xu HT, Yang LH, Wang E. X-ray irradiation induced Disabled-2 gene promoter de-methylation enhances radiosensitivity of non-small-cell lung carcinoma cells. J Exp Clin Cancer Res 2018;37:315. [PMID: 30547821 DOI: 10.1186/s13046-018-1000-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
115 Matsuyama M, Søraas A, Yu S, Kim K, Stavrou EX, Caimi PF, Wald D, deLima M, Dahl JA, Horvath S, Matsuyama S. Analysis of epigenetic aging in vivo and in vitro: Factors controlling the speed and direction. Exp Biol Med (Maywood) 2020;245:1543-51. [PMID: 32762265 DOI: 10.1177/1535370220947015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Kaufman-Szymczyk A, Majda K, Szuławska-Mroczek A, Fabianowska-Majewska K, Lubecka K. Clofarabine‑phytochemical combination exposures in CML cells inhibit DNA methylation machinery, upregulate tumor suppressor genes and promote caspase‑dependent apoptosis. Mol Med Rep 2019;20:3597-608. [PMID: 31485618 DOI: 10.3892/mmr.2019.10619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
117 Armartmuntree N, Jusakul A, Sakonsinsiri C, Loilome W, Pinlaor S, Ungarreevittaya P, Yong CH, Techasen A, Imtawil K, Kraiklang R, Suwannakul N, Kaewlert W, Chaiprasert T, Thanan R, Murata M. Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression. J Cancer 2021;12:2673-86. [PMID: 33854627 DOI: 10.7150/jca.52378] [Reference Citation Analysis]
118 Choudhuri S, Kaur T, Jain S, Sharma C, Asthana S. A review on genotoxicity in connection to infertility and cancer. Chem Biol Interact 2021;345:109531. [PMID: 34058178 DOI: 10.1016/j.cbi.2021.109531] [Reference Citation Analysis]
119 Hernández-Lemus E, Reyes-Gopar H, Espinal-Enríquez J, Ochoa S. The Many Faces of Gene Regulation in Cancer: A Computational Oncogenomics Outlook. Genes (Basel) 2019;10:E865. [PMID: 31671657 DOI: 10.3390/genes10110865] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
120 Lobo J, Henrique R, Jerónimo C. The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors. Cancers (Basel) 2018;11:E6. [PMID: 30577487 DOI: 10.3390/cancers11010006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
121 López-camarillo C, Gallardo-rincón D, Álvarez-sánchez ME, Marchat LA. Pharmaco-epigenomics: On the Road of Translation Medicine. In: Ruiz-garcia E, Astudillo-de la Vega H, editors. Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics. Cham: Springer International Publishing; 2019. pp. 31-42. [DOI: 10.1007/978-3-030-24100-1_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
122 Kaplan A, Li MJ, Malani R. Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases. Curr Oncol Rep 2022. [PMID: 35138599 DOI: 10.1007/s11912-022-01206-2] [Reference Citation Analysis]
123 Khrabrova DA, Yakubovskaya MG, Gromova ES. AML-Associated Mutations in DNA Methyltransferase DNMT3A. Biochemistry (Mosc) 2021;86:307-18. [PMID: 33838631 DOI: 10.1134/S000629792103007X] [Reference Citation Analysis]